Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
Cancer Research
|
November 4, 2005
Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods
Laura M Kenny, David M Vigushin, Adil Al-Nahhas, et al.
Journal of Clinical Pathology
|
May 19, 2011
Epidermal growth factor receptor status in early stage breast cancer is associated with cellular proliferation but not cross-talk
Justin Stebbing, Arun Thiyagarajan, Veena Surendrakumar, et al.
Metallomics : Integrated Biometal Science
|
December 10, 2014
Zinc isotopic compositions of breast cancer tissue
Fiona Larner, Laura N Woodley, Sami Shousha, et al.
Biochemical Pharmacology
|
March 14, 2019
Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases
Zimam Mahmud, Muhammad Asaduzzaman, Uttom Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2010
Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab
Laura M Kenny, Kaiyumars B Contractor, Rainer Hinz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survival
Carlo Palmieri, Eric W-F Lam, Janine Mansi, et al.
Annals of Surgical Oncology
|
March 23, 2024
Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving Surgery
Hemali Chauhan, Natasha Jiwa, Vikneswaran Raj Nagarajan, et al.
Oncotarget
|
June 21, 2015
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation
Monica Faronato, Van T M Nguyen, Darren K Patten, et al.
Breast Cancer Research and Treatment
|
January 20, 2024
Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study
R Charles Coombes, Christina Angelou, Zamzam Al-Khalili, et al.
Breast Cancer Research and Treatment
|
May 5, 2024
Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study
R Charles Coombes, Christina Angelou, Zamzam Al-Khalili, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
Cancer Research
|
November 4, 2005
Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods
Laura M Kenny, David M Vigushin, Adil Al-Nahhas, et al.
Journal of Clinical Pathology
|
May 19, 2011
Epidermal growth factor receptor status in early stage breast cancer is associated with cellular proliferation but not cross-talk
Justin Stebbing, Arun Thiyagarajan, Veena Surendrakumar, et al.
Metallomics : Integrated Biometal Science
|
December 10, 2014
Zinc isotopic compositions of breast cancer tissue
Fiona Larner, Laura N Woodley, Sami Shousha, et al.
Biochemical Pharmacology
|
March 14, 2019
Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases
Zimam Mahmud, Muhammad Asaduzzaman, Uttom Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2010
Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab
Laura M Kenny, Kaiyumars B Contractor, Rainer Hinz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survival
Carlo Palmieri, Eric W-F Lam, Janine Mansi, et al.
Annals of Surgical Oncology
|
March 23, 2024
Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving Surgery
Hemali Chauhan, Natasha Jiwa, Vikneswaran Raj Nagarajan, et al.
Oncotarget
|
June 21, 2015
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation
Monica Faronato, Van T M Nguyen, Darren K Patten, et al.
Breast Cancer Research and Treatment
|
January 20, 2024
Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study
R Charles Coombes, Christina Angelou, Zamzam Al-Khalili, et al.
Breast Cancer Research and Treatment
|
May 5, 2024
Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study
R Charles Coombes, Christina Angelou, Zamzam Al-Khalili, et al.
Page
of 6